Manufacturing Changes and Generic Approval: What Triggers FDA Re-evaluation
Discover what manufacturing changes trigger FDA re-evaluation for generic drugs. Learn about PAS, CBE, and Annual Report classifications, timelines, costs, and strategies to streamline approval.
Read More